Genetic polymorphisms in Phase I enzymes, particularly in the cytochrome P450 family, can lead to significant variations in drug metabolism among individuals. These genetic differences can influence the rate at which drugs are metabolized, impacting both the efficacy and toxicity of medications. Understanding these genetic variations is crucial for personalized medicine approaches.
